Cargando…
2020年中国慢性髓性白血病患者酪氨酸激酶抑制剂治疗状况调研
OBJECTIVE: To investigate the current status of treatment choice and responses in patients with chronic myeloid leukemia (CML) in China. METHODS: From the end of April to mid-May in 2020, a cross-sectional survey, by filling out a survey questionnaire, was conducted to explore the first-line choice...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408488/ https://www.ncbi.nlm.nih.gov/pubmed/34455739 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.07.002 |
Ejemplares similares
-
中国慢性髓性白血病患者酪氨酸激酶抑制剂治疗现状的调研:从患者的角度
Publicado: (2016) -
中国真实世界慢性髓性白血病患者停用酪氨酸激酶抑制剂的观察研究
Publicado: (2022) -
中国服用酪氨酸激酶抑制剂的慢性髓性白血病慢性期患者共存疾病状况及其对患者报告结果的影响
Publicado: (2018) -
儿童慢性髓性白血病酪氨酸激酶抑制剂停药的研究进展
Publicado: (2023) -
慢性髓性白血病患者酪氨酸激酶抑制剂治疗中发生的PH阴性髓系肿瘤
Publicado: (2019)